Cite
HARVARD Citation
Cohen, E. et al. (n.d.). 352 Updated clinical data from the squamous cell carcinoma of the head and neck (SCCHN) expansion cohort of an ongoing Ph1/1b Study of eganelisib (formerly IPI-549) in combination with nivolumab. Journal for immunotherapy of cancer. pp. A214-A215. [Online].